ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

NVS Novartis AG

97.65
0.15 (0.15%)
Pre Market
Last Updated: 13:38:46
Delayed by 15 minutes
Name Symbol Market Type
Novartis AG NYSE:NVS NYSE Depository Receipt
  Price Change % Change Price High Price Low Price Open Price Traded Last Trade
  0.15 0.15% 97.65 1,190 13:38:46

ADR Shares End Mixed; Philips Shares Drop

27/01/2015 10:37pm

Dow Jones News


Novartis (NYSE:NVS)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Novartis Charts.

International stocks trading in New York were mixed on Tuesday.

The BNY Mellon index of American depositary receipts was unchanged at 142.56. The European index increased 0.11% to 140.14, the Asian index dropped 0.43% to 146.7, the Latin American index rose 0.52% to 233.53 and the emerging markets index declined 0.3% to 273.7. Among the companies with shares that actively traded was Philips NV (PHG, PHIA.AE).

Philips warned on Tuesday that it has fallen behind its 2016 financial targets, following a number of setbacks that contributed to a 67% drop in the Amsterdam-based electronics maker's fourth-quarter net profit. The company cited a series of operational difficulties, a slowing global economy and mounting costs related to plans to split its business. The split hadn't been decided when the targets were announced in 2013. The share price fell 5.3% to $28.70.

Ericsson AB (ERIC) posted a weaker-than-expected fourth-quarter net profit and said sales growth had stalled, after North American network operators curbed investment in new high-speed wireless networks. The Sweden-based telecom equipment maker's shares fell 2.3% to $12.14.

Swiss pharmaceutical giant Novartis AG (NVS, NOVN.VX) reported fourth-quarter profit declined but said it expects its business to gain momentum this year despite uncertainty spawned by the strengthened Swiss franc. Shares rose 2.5% in price to $98.93.

Write to Tess Stynes at tess.stynes@wsj.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires


1 Year Novartis Chart

1 Year Novartis Chart

1 Month Novartis Chart

1 Month Novartis Chart

Your Recent History

Delayed Upgrade Clock